MYnd Analytics, Inc. the Company , is a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. The Company provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post traumatic stress disorder PTSD and other non psychotic disorders. The Company uses its proprietary neurometric platform, PEER Online, to generate Psychiatric EEG Evaluation Registry PEER Reports to predict the likelihood of response by an individual to a range of medications prescribed for the treatment of behavioral disorders. We will be conducting clinical trials focused on military personnel and their family members who are suffering from depression, PTSD and mild traumatic brain injury mTBI in order to support clinical decisions in the treatment of depression and related disorders. We are also planning to commercialize our PEER Report by focusing on the following four areas: i Military and Veterans, ii commercial growth strategy outside of the US, initially through the Canadian Armed Forces, which will provide both NATO and Health Canada experience with our PEER technology, iii payer and self insured markets and iv market entry of provider groups.
Quote | Mynd Life Sciences Inc Com (NASDAQ:MYND)
Last: | $ |
---|---|
Change Percent: | -15.22% |
Open: | $1.40 |
Close: | $1.17 |
High: | $1.45 |
Low: | $1.15 |
Volume: | 472,289 |
Last Trade Date Time: | 07/17/2019 04:51:31 pm |
News | Mynd Life Sciences Inc Com (NASDAQ:MYND)
2024-03-27 13:46:53 ET More on Mynd.ai Financial information for Mynd.ai Read the full article on Seeking Alpha For further details see: Mynd.ai GAAP EPS of 103.00c, revenue of RMB7.1B
Mynd Announces Fiscal Year 2023 Results PR Newswire Delivers Revenue of $413.6 Million and Successfully Completes Transformational Merger Transaction SEATTLE , March 27, 2024 /PRNewswire/ -- Mynd.ai, Inc. (the "Company" or "...
Message Board Posts | Mynd Life Sciences Inc Com (NASDAQ:MYND)
Subject | By | Source | When |
---|---|---|---|
$MYNDF MYND Life Sciences Provides Update on Depression | AskMuncher | investorshub | 12/16/2021 4:45:49 PM |
Nice | Sixman | investorshub | 10/09/2019 6:26:51 PM |
It's too bad that people on the yahoo | Norgy | investorshub | 09/29/2019 1:53:25 PM |
See news... | Don | investorshub | 07/18/2019 7:20:11 PM |
Hmmm halted? | ThoughtPower | investorshub | 07/18/2019 6:06:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Mynd Life Sciences Inc Com Company Name:
MYND Stock Symbol:
NASDAQ Market:
Mynd Life Sciences Inc Com Website:
Mynd Announces Fiscal Year 2023 Results PR Newswire Delivers Revenue of $413.6 Million and Successfully Completes Transformational Merger Transaction SEATTLE , March 27, 2024 /PRNewswire/ -- Mynd.ai, Inc. (the "Company" or "...
Promethean wins three Tech & Learning Awards of Excellence for 2023 Promethean wins three Tech & Learning Awards of Excellence for 2023 PR Newswire The company was recognized for its ActivPanel LX display, OPS-A computing module, and Explain Everything Advanced les...
Mynd.ai to Ring NYSE First Trade Bell on February 5th PR Newswire SEATTLE , Feb. 2, 2024 /PRNewswire/ -- Mynd.ai, Inc. ("Mynd" or the "Company") (NYSE American: MYND), today announced that Vin Riera , CEO, alongside members of Mynd's executive management team...